FdaApplication

ANDA 203896

Back to search

Identifiers

Properties

PropertyValue
applicant_nameANDAS 5 HOLDING LLC
application_typeANDA
approval_date2017-02-02

Products (2)

ProductActive ingredientStrengthDosage form
EPLERENONEEPLERENONE50MGTABLET;ORAL
EPLERENONEEPLERENONE25MGTABLET;ORAL

2 products